MASCT is under clinical development by Hengrui Yuanzheng Biotechnology and currently in Phase I for Solid Tumor.
FDA targets more online vendors selling unapproved GLP-1RA products – Pharmaceutical Technology
Online GLP-1RA products have become more prevalent amid popularity of Novo Nordisk’s and Eli Lilly’s approved treatments. Image credit: Shutterstock/ zimmytws. The US Food and